Coactivator condensation drives cardiovascular cell lineage specification

Peiheng Gan,Mikayla Eppert,Nancy De La Cruz,Heankel Lyons,Akansha M Shah,Reshma T Veettil,Kenian Chen,Prashant Pradhan,Svetlana Bezprozvannaya,Lin Xu,Ning Liu,Eric N Olson,Benjamin R Sabari,Akansha M. Shah,Reshma T. Veettil,Eric N. Olson,Benjamin R. Sabari

DOI: https://doi.org/10.1126/sciadv.adk7160

IF: 13.6

2024-03-17

Science Advances

Abstract:During development, cells make switch-like decisions to activate new gene programs specifying cell lineage. The mechanisms underlying these decisive choices remain unclear. Here, we show that the cardiovascular transcriptional coactivator myocardin (MYOCD) activates cell identity genes by concentration-dependent and switch-like formation of transcriptional condensates. MYOCD forms such condensates and activates cell identity genes at critical concentration thresholds achieved during smooth muscle cell and cardiomyocyte differentiation. The carboxyl-terminal disordered region of MYOCD is necessary and sufficient for condensate formation. Disrupting this region's ability to form condensates disrupts gene activation and smooth muscle cell reprogramming. Rescuing condensate formation by replacing this region with disordered regions from functionally unrelated proteins rescues gene activation and smooth muscle cell reprogramming. Our findings demonstrate that MYOCD condensate formation is required for gene activation during cardiovascular differentiation. We propose that the formation of transcriptional condensates at critical concentrations of cell type–specific regulators provides a molecular switch underlying the activation of key cell identity genes during development.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper primarily discusses how the cardiovascular transcriptional coactivator Myocardin (MYOCD) activates cell identity genes by forming concentration-dependent and switch-like transcriptional complexes, thereby driving the specialization of the cardiovascular cell lineage. Specifically, the study found that MYOCD forms transcriptional complexes at critical concentration thresholds during the differentiation of smooth muscle cells (SMC) and cardiomyocytes (CM), activating cell identity genes. The disordered region at the C-terminus of MYOCD is crucial for the formation of these complexes, and disruption of this region affects gene activation and the reprogramming of smooth muscle cells. Partial restoration of gene activation and smooth muscle cell reprogramming can be achieved by replacing this region of MYOCD with disordered regions from functionally unrelated proteins. The study also demonstrates how the MYOCD complex selectively enriches components involved in active transcription, such as RNA polymerase II and histone H3K27 acetylation, as well as co-localization with transcriptional sites of lineage-specific genes.

Furthermore, researchers used human induced pluripotent stem cells (hiPSCs) for modeling and observed that MYOCD forms complexes at endogenous concentrations during the differentiation of SMC and CM, and the formation of these complexes is directly related to the activation of gene expression reporters. Additional experiments revealed the molecular basis for the formation of MYOCD complexes, including the role of the MYOCD transcriptional activation domain (TAD) and the importance of its aromatic residues for complex formation. When these key structures are removed or mutated, not only is complex formation hindered, but gene activation function is also impaired. However, by replacing the TAD with disordered regions from other proteins known to promote complex formation, such as those from FUS and TAF15, the ability of MYOCD to form complexes and activate genes can be restored, proving that complex formation is necessary for MYOCD's gene activation capability.